When Words
Fail.

A man with a moderate intellectual disability, settled for years, begins to hit himself and refuse food. The chart offers a ready explanation, the one always within reach: it is the disability. That sentence ends the assessment before it starts, and it is wrong often enough to be dangerous. A changed behaviour in a person who cannot easily say what is wrong is not a diagnosis. It is a signal with at least three readings, and the work is telling them apart.

The readings compete. The behaviour may be a new psychiatric illness, expressed as conduct because the words for it are not available. It may be a physical illness or pain, a toothache, constipation, an ear infection, reflux, a fracture, speaking through the only channel left. It may be distress or an unmet need, a change of staff, a loss, boredom, fear, or a demand that cannot be met. Or it may be near the person's baseline, a lifelong pattern now merely more visible. Psychiatric illness in intellectual disability is common, treatable, and routinely missed, and it is missed for reasons that are predictable enough to be designed around.^1,2

Why standard psychiatry mis-fires here

• The criteria assume a narrator. Most of our diagnostic anchors, low mood reported, worthlessness, racing thoughts, delusional content, were written for patients who can describe an inner world. As intellectual disability deepens, that self-report thins and then vanishes, so the standard manuals undercount: in the landmark population study the point prevalence of mental ill-health was 40.9% by clinical judgement but only 15.7% by DSM-IV-TR, with the disability-specific criteria capturing more than twice as much.¹
• The illness is shown, not spoken. Limited abstraction, a sparse emotional vocabulary, and constrained communication mean distress surfaces as behaviour. The clinician reads conduct and must infer the state behind it, which is why a careful behavioural baseline, and an informant who knows the person, outrank any single interview.^3,7
• The reflex is to blame the disability. The single most studied error in this field is to attribute a symptom to the intellectual disability itself, so a coexisting and treatable illness is never sought. It has a name, diagnostic overshadowing, and the rest of this issue is built to counter it.²

The concept code used throughout: severity by adaptive function

Each colour is also a shape, so the code survives a greyscale photocopy. Severity is the axis that governs everything that follows: the deeper the disability, the further assessment shifts from what the person says to what they do and what those around them observe. The figure overleaf places the four bands on that single continuum.

Intellectual disability is defined by three things together: deficits in intellectual functioning, deficits in adaptive functioning across the conceptual, social and practical domains, and onset in the developmental period. The decisive modern move, made explicit in DSM-5 and in ICD-11 (which renames the condition disorders of intellectual development), is away from a single IQ cut-off and toward adaptive function as the basis for grading severity. A WHO-led panel built behavioural indicators of adaptive function for exactly this purpose, to let a clinician grade severity by what a person can do where standardised testing is unavailable, and an international field study including two Indian sites found them reliable and usable across all severity bands.^8,9 The IQ bands have not disappeared, but they now sit alongside the adaptive picture rather than defining it.¹⁰

Aetiology, in brief. Causes group into genetic and chromosomal, prenatal (infection, toxins, alcohol), perinatal (hypoxia, prematurity) and postnatal (infection, trauma, malnutrition), with a once-large idiopathic fraction now shrinking as microarray and sequencing reclassify it.¹¹ Clinical genomic testing yields a diagnosis in roughly a quarter of cases on pooled data, more with exome or genome testing, but the same review found no sequencing studies from India, Africa or Latin America, a stark reminder that aetiological work-up is a privilege of resource.¹² Intellectual disability is more prevalent in low- and middle-income countries, near 10.4 per 1000 worldwide on the best meta-analysis, which was led from an Indian group.¹³

How to read this Walk left to right; as the band deepens the population share falls and the symptom channel slides from what the person says to what they do.

Population shares are the conventional textbook proportions; the point is the order and the gradient, not the exact percentage. Borderline intellectual functioning (IQ about 70 to 85) sits just above the threshold and carries raised psychiatric and adaptive risk without meeting criteria for the disability.¹⁰

Psychiatric comorbidity in intellectual disability is the rule, not the exception. The reported range is enormous, from 7% to 97% across studies, because everything depends on case definition and on whether behaviour that challenges is counted.¹ The defensible headline is that any co-occurring psychiatric disorder runs at roughly a third on pooled meta-analysis in adults, around 34%, and 38 to 49% in children, both well above general-population rates though with wide between-study variation.^20,21 The child total-population work found over 40% with a significant disorder, yet fewer than one in ten with a major disorder had received specialist help.^18,19 Rates are not flat across cause: adults with Down syndrome carry less mental ill-health than other adults with intellectual disability, a useful caution against assuming a uniform dose-response.²²

The under-count is the message. In the same population the standard manuals saw less than half of what a clinician using disability-adapted criteria saw. Three predictable errors stand between the clinician and the diagnosis, and naming them is half the cure.¹

Trap 1: diagnostic overshadowing

The reflex to attribute a symptom to the disability itself, so a coexisting illness is never sought. It was demonstrated experimentally: the identical phobia was judged less likely to be an emotional disorder once the person was also labelled as having an intellectual disability, and the same held for psychosis and personality-disorder vignettes.² It is not abolished by experience, which marks it as a structural bias rather than a training gap.⁴ The modern systematic review tempers the absolutism, one study in three found no overshadowing and the evidence is of low quality, so the right posture is not fatalism but vigilance: treat overshadowing as a high prior to be actively countered, not an inevitability.⁵

Trap 2: behavioural equivalents, used with care

Because symptoms are shown not spoken, a psychiatric illness often surfaces as a change in behaviour, and the disability-specific frameworks allow such behavioural equivalents to stand in for criteria that require words. This is real and useful, but it is contested, and the caution is important: challenging behaviours are robustly associated with depression yet should not be uncritically relabelled as depressive equivalents, because the same behaviours used to make the diagnosis are then used to confirm it, a circularity that inflates everything.^6,7,23 The safe rule: a behaviour change is a red flag that prompts assessment, never a diagnosis in itself.

Trap 3: Sovner's four factors

Sovner named four ways the criteria distort in intellectual disability, and they remain the field's working lens.³

• Intellectual distortion: concrete thinking limits the reporting of abstract internal states.
• Psychosocial masking: limited life experience flattens symptom content, so a delusion may be simple or a manic grandiosity unsophisticated.
• Cognitive disintegration: stress-induced decompensation produces disorganised behaviour that can be mistaken for psychosis.
• Baseline exaggeration: illness amplifies the pre-existing behavioural baseline rather than adding textbook symptoms, which is why a recorded baseline is the comparator that lets you see the change.

Each row is a disorder; the columns move from the textbook picture, to how it changes when the patient cannot narrate it, to the most useful adaptation for finding it. The sections that follow expand each row and carry the citations.

The first column is the trap, the second the truth, the third the move. The thread through the third column is informant history plus a behavioural baseline.

Depression is among the most common and most missable comorbidities. The prospective population data give a two-year incidence of 7.2%, broadly comparable to the general population, but the presentation diverges sharply, and the strongest single predictor of a new depressive episode in that cohort was the presence of challenging behaviour, which more than doubled the odds.²⁴ The lesson is in that statistic: in intellectual disability, depression often arrives wearing the clothes of behaviour.

How the picture changes with severity. In mild disability the textbook features survive, with low mood and anhedonia reportable if asked plainly. As disability deepens, the presentation shifts toward observed signs: a loss of acquired adaptive skills, social withdrawal, irritability and aggression, disturbed sleep and appetite, and the onset or worsening of challenging behaviour.²⁵ The most rigorous synthesis in severe-to-profound disability confirms that the core features, depressed affect and anhedonia, do still relate to depression alongside irritability, sleep disturbance, psychomotor change and appetite loss, but it cautions firmly against treating aggression, screaming and self-injury as depressive equivalents in their own right, because pain, autism and other affective disorders confound them.⁷ The clinic data make the practical point bluntly: sad mood, crying and anhedonia are what separate depression from everything else, yet most patients with intellectual disability cannot meet the required count of standard or even adapted criteria, so the diagnosis leans on observed change against a known baseline.²⁶

Suicidality is reported by few patients with significant disability, but it is not absent; it must be asked about directly and in plain language, and a documented decline in self-care or new self-injury can be its only sign.^26,23

Mania is the quietly remarkable finding of the incidence data. In the prospective cohort, first-episode mania occurred at a standardised incidence ratio above 40 compared with the general population, a relative excess on the order of schizophrenia, and yet, as the authors note, it has received remarkably little attention.²⁴ Part of the reason is that elated mood and grandiosity, the features clinicians watch for, are exactly the ones that the disability flattens and that overactive, irritable behaviour obscures.

What mania looks like here. Reliance shifts from reported elation to observed state: overactivity, irritability, a reduced need for sleep, increased and pressured vocalisation, and behavioural escalation. In the comparative clinic series, patients with bipolar disorder were set apart from those with depression by elevated mood, acute anger, increased speech, sexual themes and increased appetite, and they showed the most pronounced challenging behaviour of any diagnostic group.²⁶ The single most useful instrument is not a scale but a timeline: episodicity, a change from a known baseline, and any seasonality are what convert a confusing behavioural picture into a recognisable affective one.

Two practical cautions

• Do not confuse mania with ADHD or with challenging behaviour. Overactivity and impulsivity are shared; episodicity is not. A discrete change from baseline, with reduced sleep and elevated or irritable mood, points to mania, where a lifelong, non-episodic pattern points to ADHD or to behaviour with an environmental function.²⁴
• Rapid cycling may behave differently. On a small and dated evidence base, a systematic review suggests rapid-cycling bipolar disorder in intellectual disability may differ from the general-population form, with a male preponderance, earlier onset, and a poorer response to lithium prophylaxis, worth holding when prophylaxis is being planned.²⁷

High baseline mood-stabiliser use alongside high mania incidence in the cohort suggests enduring, under-treated illness rather than over-treatment, an unusual direction for this population and a reason to hold mania actively in mind.²⁴

Anxiety. Diagnosable anxiety disorders run at around 3.8% by formal criteria in adults with intellectual disability, generalised anxiety commonest, though this almost certainly undercounts because the defining experience is internal.²⁸ The presentation is behavioural: avoidance, agitation, increased vocalisation, somatic complaints and behaviour that challenges, frequently set off by a change to routine. Carers and clinicians of minimally verbal people converge on the same heuristics, know the person, establish their behavioural baseline, and actively rule out other sources of distress, especially pain, before settling on anxiety.³⁰ Anxiety here also takes forms beyond the standard categories, notably intolerance of uncertainty, which persists across the lifespan and is easily missed.²⁹ Where mild disability permits, the Glasgow Anxiety Scale is a validated self-report; otherwise an informant measure such as the ADAMS anxiety subscale carries the assessment.³¹

OCD, and the differentiation that matters. The central task is to separate genuine obsessive-compulsive disorder from stereotypy, restricted and repetitive behaviour, and autistic sameness. The DSM anchors, egodystonia and inner resistance, are unreliable or simply unassessable at lower verbal levels. The foundational work showed compulsions occurring without any recognisable egodystonic quality, and, crucially, that trained raters could reliably distinguish compulsions from stereotypies on observable features while inner-resistance and subjective-distress items added nothing, which argues for a behavioural, externally observable approach.³² The modern review confirms substantial overlap between autistic repetitive behaviour and compulsions at the level of content and intensity, so differentiation rests on function.³³

In Indian practice self-report tools need linguistic and cultural adaptation, so informant report plus behavioural baselining is the pragmatic default.³⁴

Psychotic disorders are markedly over-represented, but the size of the excess depends on how cases are found. The careful population study put clinical psychosis at about three times the general-population rate; whole-system register studies, which capture every diagnosed case, report relative risks in the region of eight- to twelve-fold, among the largest psychiatric excesses in this population, and highest in mild disability where the diagnosis is most feasible.^35,36,20 Both figures are true; the discrepancy is itself the teaching point, because the lower the verbal level, the harder the diagnosis is to make at all.

The verbal floor. A reliable diagnosis of schizophrenia depends on self-reported inner experience: first-rank symptoms, formal thought disorder, the elaboration of a delusion. These require a verbal mental age roughly above that of moderate disability; below it they cannot be elicited or distinguished from developmentally expected behaviour. The consequence is over-diagnosis at the bottom of the range, where one clinical series found that careful review reclassified five of seven psychosis-not-otherwise-specified cases as non-psychotic, and where that residual label carried the worst outcomes.³⁷ Sovner's four factors are the working lens: intellectual distortion and psychosocial masking simplify and flatten any genuine content, while cognitive disintegration, stress-induced disorganisation, produces behaviour that mimics psychosis without being it.³

Separating true psychosis from its mimics

• Self-talk, imaginary companions and fantasy are developmentally expected at lower mental ages and are not hallucinations or delusions.
• Fear and odd responses to unseen stimuli may reflect sensory impairment, pain or anxiety before they reflect psychosis; exclude those first.
• A discrete change from baseline, corroborated by an informant and persisting over time, is worth far more than any single cross-sectional sign.

The disability-specific criteria were built precisely because the standard manuals fail here; the DC-LD was validated against expert clinical opinion, and a tiered, parallel patient-and-informant interview such as the PAS-ADD is the structured route to a defensible diagnosis below the verbal floor.^38,39

ADHD. ADHD is among the most prevalent diagnosed psychiatric disorders in children with intellectual disability, at roughly 30%, against a general-population childhood rate near 5 to 7%.^21,40 The whole assessment turns on one rule: symptoms must be excessive for the person's developmental, that is mental, age, not their chronological age, because slower-paced attention and higher activity can be developmentally typical for the mental age. Judged against chronological age, almost everyone with significant disability looks inattentive and overactive; judged against developmental age and a known baseline, genuine ADHD separates out.

Treatment response, and a heavier side-effect burden. Stimulants work, but less robustly and with more adverse effects than in typically developing children. The definitive double-blind trial in children with ADHD and intellectual disability found optimally titrated methylphenidate beat placebo, but with effect sizes around half those seen in the general ADHD population and clear sleep, appetite and weight effects.⁴¹ The scoping review confirms methylphenidate and atomoxetine help and are generally tolerated, though the trials are small and few.⁴² Where autism co-occurs, the response is further attenuated by lower IQ and treatment-emergent irritability and mood lability are common, so the rule is start low, titrate slowly, and monitor closely.⁴³

The autism overlap (a note, not a section)

• They travel together. Within autism, intellectual disability co-occurs in roughly a quarter and ADHD in another quarter; in population data most children with autism also have an intellectual disability.^44,45 The combination is the norm, not the exception, and it raises the rate of every other comorbidity.
• Differentiate by proportion, not by delay. Autism is distinguished from intellectual disability alone when the social-communication impairment and the restricted, repetitive behaviour are out of proportion to the global developmental delay, rather than merely tracking it. A delayed child relates in keeping with their mental age; an autistic child does not.
• The shared trap is overshadowing. Once one neurodevelopmental label is fixed, new symptoms get folded into it. The systematic review tempers but does not dismiss the bias; structured, informant-based reassessment is the antidote, not assumption.⁵

Behaviour that challenges is a description, not a diagnosis. Emerson's foundational work established the principle that anchors everything: there is no reliable mapping from the form of a behaviour to its function. The same aggression or self-injury serves different purposes in different people, and function is more consistent within a person across behaviours than across people who share a behaviour.⁴⁶ It is common, shown by 10 to 15% of people with intellectual disability in contact with services, more often male, clustering in adolescence and young adulthood, and strongly tied to restricted communication, which is the clue to its nature.⁴⁷ It is a final common pathway for illness, pain, an unmet need and a difficult environment, and treating it as a diagnosis to be medicated is the central error of the field.

Functional analysis is the method. Iwata's experimental work resolved the functions of self-injury into three broad classes that remain the working taxonomy: social-negative reinforcement or escape from demands, social-positive reinforcement such as attention or a tangible, and automatic or sensory reinforcement.⁴⁸ Establishing which function is operating is what turns an intractable behaviour into a treatable one. The evidence on outcomes is sobering and clarifying at once: a meta-analysis of 82 trials found only small effect sizes overall and, decisively, no significant difference between drug and non-drug approaches, which is why guidelines place psychological, behavioural and environmental work first.⁴⁹

Self-injury, and the search behind it. Self-injury, head-banging, biting, skin-picking, eye-poking, is common and can be life-threatening. It is markedly elevated in specific genetic syndromes, Cornelia de Lange, Cri du Chat, Fragile X, Prader-Willi, Lowe and Smith-Magenis among them, with Lesch-Nyhan syndrome the paradigm of compulsive self-mutilation as a defining phenotype.^50,51,52 Crucially, it is often a behavioural equivalent of untreated pain: a documented case of severe, near-fatal self-harm resolved only when somatic pain sources were systematically treated.⁵³ People with intellectual disability carry a high physical and mental multimorbidity at younger ages than the general population, which is exactly why a new or escalating behaviour mandates a medical and psychiatric search before any behavioural attribution.^54,55

A behavioural equivalent is a prompt to assess, not a diagnosis. The same conduct can sit in any of these rows, which is why the equivalent narrows the search but the cause is confirmed by the work-up, not by the behaviour.

Assessment here reorders ordinary psychiatric practice. Collateral history and direct behavioural observation outrank self-report, and the more severe the disability the more weight shifts to the informant, until in profound disability the assessment is wholly observational. Self-rating is feasible only in mild disability, and even there it must be cross-checked. This is why almost every validated instrument in the field is built around a carer, and why the diagnostic frameworks were rewritten to accommodate how disorder actually presents.

The frameworks. The DC-LD was devised because ICD-10 and DSM-IV demonstrably miss disorder in adults with intellectual disability; in its field trial it agreed with expert clinical opinion in 96% of cases.³⁸ The DM-ID, the North American adaptation of DSM, is rated easy to use and reduces reliance on vague residual categories.⁶ Both encode the same insight: criteria written for a narrator must be adapted for a patient who communicates through behaviour.

Choose by verbal level and question: a framework to diagnose (DC-LD, DM-ID-2), a structured interview to assess (PAS-ADD family), a symptom scale to measure and follow (GDS-LD, GAS-ID, ABC, DASH-II), or a screen to case-find (Checklist, Reiss).^{39,56,57,58,59,60,61,62} The instruments force the right examination and make change measurable across visits, which is how a baseline becomes a comparator.

Management rests on a hard evidence anchor. In the landmark trial, haloperidol, risperidone and placebo were compared for aggressive challenging behaviour in adults with intellectual disability; aggression fell in all three arms but active drug was not superior to placebo, a difference that did not reach significance. Antipsychotics, the authors concluded, should no longer be a routine treatment for it.⁶³ The guidance that follows puts psychological, behavioural and environmental work first, and warns against letting challenging behaviour become a pseudo-diagnosis a drug is aimed at.⁵⁵ The over-prescription is the corollary: in a large cohort half of adults with intellectual disability had a psychotropic prescription but only a fifth a recorded mental illness, the prescribing driven by challenging behaviour, autism and dementia, not psychosis.⁶⁴

Why start low, and go slow. Adults with intellectual disability on antipsychotics have more movement side effects than matched controls and a several-fold higher rate of neuroleptic malignant syndrome, so the same dose carries more harm.⁶⁵ A drug used here should have one target, the lowest dose, a time limit and active monitoring, and it should be reviewable: long-term risperidone could be withdrawn in most patients without a rise in irritability and with metabolic gains, the evidence under STOMP, Stopping Over-Medication of People with intellectual disability, autism or both.⁶⁶ STOMP advances where teams are resourced and stalls where they are not, and behavioural care must be delivered well rather than assumed, since positive behaviour support training alone did not reduce challenging behaviour in a cluster trial.^67,68,69

Blaming the disability. The commonest and most damaging error is diagnostic overshadowing: reading a new symptom as part of the intellectual disability, so a treatable illness is never sought. It was shown experimentally and is not cured by experience, which marks it as a structural reflex rather than a knowledge gap.^2,4 The modern evidence says it is real but not universal, so the corrective is not despair but a habit: when a behaviour changes, ask what is new, not what is expected, and work the readings before reaching for the disability as the answer.⁵

Treating the behaviour instead of the cause. Behaviour that challenges invites a prescription, and the prescription is usually an antipsychotic. But for aggression without a psychiatric indication the antipsychotic is no better than placebo and adds real harm, and behaviour that challenges is a final common pathway, not a diagnosis.^63,65 The error is to medicate the topography and skip the function. The fix is the work-up: a functional analysis and a search for pain, illness, distress and environment, because the same behaviour can be any of them.^53,54

Mistaking the behaviour for a diagnosis, or for none. The two opposite failures meet here. One is to seize on a behavioural equivalent and call it depression because the person is aggressive, when aggression has many causes and the same behaviours used to diagnose then circularly confirm it.^7,23 The other is to dismiss a genuine, treatable illness as merely behavioural. Between them sits the discipline of this issue: a behaviour change is a prompt to assess against a baseline, neither a diagnosis to assume nor a noise to ignore.

Psychiatric illness in intellectual disability is common, treatable, and missed for reasons that can be designed around. Almost all of the skill is reading a behaviour for what it is, in a fixed order, against a baseline, with the right informant.

What this issue comes down to

1. The behaviour is shown, not spoken. As the disability deepens, self-report thins and then vanishes, so illness reaches you as a change in conduct. A documented baseline and an informant who knows the person are the instruments that read it; the deeper the disability, the more the assessment is observational.
2. Work the readings in order. Exclude physical illness and pain, then environment and communication, then assess for psychiatric illness. The cheapest and most reversible causes come first, and the psychiatric assessment is reached, not skipped to.
3. Overshadowing is the default error. Blaming the disability is the reflex that hides a treatable illness. Counter it deliberately: ask what is new, not what is expected. Each disorder presents differently here, but it presents.
4. Treat the cause, prescribe sparingly, review always. Behaviour that challenges is a final common pathway, not a diagnosis; antipsychotics are no better than placebo for aggression without a psychiatric indication and carry more harm here. Behavioural and psychological approaches come first, and any drug is one defined target, the lowest dose, time-limited, monitored, and reviewed under STOMP.

1. 1 Cooper SA, Smiley E, Morrison J, Williamson A, Allan L. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry. 2007. PMID 17197653
2. 2 Reiss S, Levitan GW, Szyszko J. Emotional disturbance and mental retardation: diagnostic overshadowing. Am J Ment Defic. 1982. PMID 7102729
3. 3 Sovner R. Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacol Bull. 1986. PMID 3809370
4. 4 Reiss S, Szyszko J. Diagnostic overshadowing and professional experience with mentally retarded persons. Am J Ment Defic. 1983. PMID 6829617
5. 5 Dell'Armo K, Tasse MJ. Diagnostic overshadowing of psychological disorders in people with intellectual disability: a systematic review. Am J Intellect Dev Disabil. 2024. PMID 38411245
6. 6 Fletcher RJ, Havercamp SM, et al. Clinical usefulness of the Diagnostic Manual-Intellectual Disability (DM-ID) for mental disorders in persons with intellectual disability: results from a brief field survey. J Clin Psychiatry. 2009. PMID 19497248
7. 7 Eaton C, Tarver J, et al. A systematic review of the behaviours associated with depression in people with severe-profound intellectual disability. J Intellect Disabil Res. 2021. PMID 33426741
8. 8 Tasse MJ, Balboni G, et al. Developing behavioural indicators for intellectual functioning and adaptive behaviour for ICD-11 disorders of intellectual development. J Intellect Disabil Res. 2019. PMID 30628126
9. 9 Lemay KR, Kogan CS, et al. An international field study of the ICD-11 behavioural indicators for disorders of intellectual development. J Intellect Disabil Res. 2022. PMID 35170825
10. 10 Fernell E, Gillberg C. Borderline intellectual functioning. Handb Clin Neurol. 2020. PMID 32977897
11. 11 Galasso C, Lo-Castro A, et al. "Idiopathic" mental retardation and new chromosomal abnormalities. Ital J Pediatr. 2010. PMID 20152051
12. 12 Stefanski A, Calle-Lopez Y, et al. Clinical sequencing yield in epilepsy, autism spectrum disorder, and intellectual disability: a systematic review and meta-analysis. Epilepsia. 2020. PMID 33200402
13. 13 Maulik PK, Mascarenhas MN, et al. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil. 2011. PMID 21236634
14. 14 Sterkenburg PS, Ilic M, et al. More than a physical problem: the effects of physical and sensory impairments on the emotional development of adults with intellectual disabilities. Int J Environ Res Public Health. 2022. PMID 36554959
15. 15 Hithersay R, Startin CM, et al. Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol. 2019. PMID 30452522
16. 16 Boyle L, Kaufmann WE. The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet. 2010. PMID 20981777
17. 17 Cassidy SB, Schwartz S, et al. Prader-Willi syndrome. Genet Med. 2012. PMID 22237428
18. 18 Einfeld SL, Tonge BJ. Population prevalence of psychopathology in children and adolescents with intellectual disability: II. Epidemiological findings. J Intellect Disabil Res. 1996. PMID 8731467
19. 19 Emerson E. Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. J Intellect Disabil Res. 2003. PMID 12558695
20. 20 Mazza MG, Rossetti A, Crespi G, Clerici M. Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability: a systematic review and meta-analysis. J Appl Res Intellect Disabil. 2019. PMID 31430018
21. 21 Buckley N, Glasson EJ, Chen W, et al. Prevalence estimates of mental health problems in children and adolescents with intellectual disability: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2020. PMID 32475125
22. 22 Mantry D, Cooper SA, Smiley E, et al. The prevalence and incidence of mental ill-health in adults with Down syndrome. J Intellect Disabil Res. 2008. PMID 18197953
23. 23 Davies LE, Oliver C. The purported association between depression, aggression, and self-injury in people with intellectual disability: a critical review of the literature. Am J Intellect Dev Disabil. 2014. PMID 25148058
24. 24 Cooper SA, Smiley E, Allan L, Morrison J. Incidence of unipolar and bipolar depression, and mania in adults with intellectual disabilities: prospective cohort study. Br J Psychiatry. 2018. PMID 29540250
25. 25 Marston GM, Perry DW, Roy A. Manifestations of depression in people with intellectual disability. J Intellect Disabil Res. 1997. PMID 9430051
26. 26 Hurley AD. Depression in adults with intellectual disability: symptoms and challenging behaviour. J Intellect Disabil Res. 2008. PMID 18680532
27. 27 Vanstraelen M, Tyrer SP. Rapid cycling bipolar affective disorder in people with intellectual disability: a systematic review. J Intellect Disabil Res. 1999. PMID 10546959
28. 28 Reid KA, Smiley E, Cooper SA. Prevalence and associations of anxiety disorders in adults with intellectual disabilities. J Intellect Disabil Res. 2011. PMID 21205039
29. 29 Groves L, et al. Divergent presentation of anxiety in high-risk groups within the intellectual disability population. J Neurodev Disord. 2022. PMID 36199025
30. 30 Edwards G, et al. Utilising interview methodology to inform the development of new clinical assessment tools for anxiety in autistic individuals who speak few or no words. J Autism Dev Disord. 2022. PMID 35304663
31. 31 Hermans H, van der Pas FH, Evenhuis HM. Instruments assessing anxiety in adults with intellectual disabilities: a systematic review. Res Dev Disabil. 2011. PMID 21330101
32. 32 Vitiello B, Spreat S, Behar D. Obsessive-compulsive disorder in mentally retarded patients. J Nerv Ment Dis. 1989. PMID 2703828
33. 33 O'Loghlen J, et al. Repetitive behaviors in autism and obsessive-compulsive disorder: a systematic review. J Autism Dev Disord. 2024. PMID 38652373
34. 34 Freeman RD, Soltanifar A, Baer S. Stereotypic movement disorder: easily missed. Dev Med Child Neurol. 2010. PMID 20187883
35. 35 Bakken TL, Sandberg M, Axmon A. Schizophrenia in children, adults and older people with intellectual disability compared with the general population: a Swedish register study. Gen Psychiatr. 2024. PMID 39687215
36. 36 Brown RC, Abrahamsson L, Sundquist J, et al. Elevated psychiatric and substance use disorders in people with intellectual disabilities in a Swedish national sample. Psychol Med. 2025. PMID 41459592
37. 37 Friedlander RI, Donnelly T. Early-onset psychosis in youth with intellectual disability. J Intellect Disabil Res. 2004. PMID 15312054
38. 38 Cooper SA, Melville CA, Einfeld SL. Psychiatric diagnosis, intellectual disabilities and the DC-LD. J Intellect Disabil Res. 2003. PMID 14516368
39. 39 Moss S, Patel P, Prosser H, et al. Psychiatric morbidity in older people with moderate and severe learning disability. I: Development and reliability of the patient interview (PAS-ADD). Br J Psychiatry. 1993. PMID 8252286
40. 40 Dalsgaard S, et al. Incidence rates and cumulative incidences of the full spectrum of diagnosed mental disorders in childhood and adolescence. JAMA Psychiatry. 2020. PMID 31746968
41. 41 Simonoff E, Taylor E, Baird G, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe ADHD and intellectual disability. J Child Psychol Psychiatry. 2012. PMID 22676856
42. 42 Miller J, Perera B, Shankar R. Clinical guidance on pharmacotherapy for the treatment of ADHD for people with intellectual disability. Expert Opin Pharmacother. 2020. PMID 32692263
43. 43 Joshi G, Wilens T, Firmin ES, et al. Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: a systematic review. J Psychopharmacol. 2021. PMID 33349107
44. 44 Mutluer T, Aslan Genc H, Ozcan Morey A, et al. Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: a meta-analysis. Front Psychiatry. 2022. PMID 35693977
45. 45 Bourke J, de Klerk N, Smith T, Leonard H. Population-based prevalence of intellectual disability and autism spectrum disorders in Western Australia. Medicine (Baltimore). 2016. PMID 27227936
46. 46 Emerson E, Bromley J. The form and function of challenging behaviours. J Intellect Disabil Res. 1995. PMID 8555715
47. 47 Emerson E, et al. The prevalence of challenging behaviors: a total population study. Res Dev Disabil. 2001. PMID 11263632
48. 48 Iwata BA, et al. The functions of self-injurious behavior: an experimental-epidemiological analysis. J Appl Behav Anal. 1994. PMID 8063623
49. 49 Groves L, et al. Non-pharmacological and pharmacological interventions for behaviours that challenge in people with intellectual disabilities: a systematic review and meta-analysis of RCTs. Lancet Psychiatry. 2023. PMID 37595996
50. 50 Huisman S, et al. Self-injurious behavior. Neurosci Biobehav Rev. 2017. PMID 28694012
51. 51 Arron K, et al. The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res. 2010. PMID 20977515
52. 52 Kelley RE, Andersson HC. Disorders of purines and pyrimidines. Handb Clin Neurol. 2014. PMID 24365355
53. 53 Cravero C, et al. Cornelia de Lange and Ehlers-Danlos: comorbidity of two rare syndromes. BMJ Case Rep. 2016. PMID 26833951
54. 54 Cooper SA, et al. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract. 2015. PMID 26310664
55. 55 Oliver-Africano P, Murphy D, Tyrer P. Aggressive behaviour in adults with intellectual disability: defining the role of drug treatment. CNS Drugs. 2009. PMID 19845412
56. 56 Prosser H, Moss S, et al. Reliability and validity of the Mini PAS-ADD for assessing psychiatric disorders in adults with intellectual disability. J Intellect Disabil Res. 1998. PMID 9786440
57. 57 Moss S, Prosser H, et al. Reliability and validity of the PAS-ADD Checklist for detecting psychiatric disorders in adults with intellectual disability. J Intellect Disabil Res. 1998. PMID 9617701
58. 58 Cuthill FM, Espie CA, Cooper SA. Development and psychometric properties of the Glasgow Depression Scale for people with a Learning Disability. Br J Psychiatry. 2003. PMID 12668412
59. 59 Mindham J, Espie CA. Glasgow Anxiety Scale for people with an Intellectual Disability (GAS-ID). J Intellect Disabil Res. 2003. PMID 12558692
60. 60 Aman MG, et al. The Aberrant Behavior Checklist: factor structure and the effect of subject variables in American and New Zealand facilities. Am J Ment Defic. 1987. PMID 3591845
61. 61 Vargas-Vargas C, et al. Validity and reliability of the Spanish version of the Diagnostic Assessment for the Severely Handicapped (DASH-II). Res Dev Disabil. 2014. PMID 25462514
62. 62 Sturmey P, Bertman LJ. Validity of the Reiss Screen for Maladaptive Behavior. Am J Ment Retard. 1994. PMID 7803036
63. 63 Tyrer P, et al. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial (NACHBID). Lancet. 2008. PMID 18177776
64. 64 Sheehan R, Hassiotis A, et al. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study. BMJ. 2015. PMID 26330451
65. 65 Sheehan R, Horsfall L, et al. Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study. BMJ Open. 2017. PMID 28775195
66. 66 Ramerman L, de Kuijper G, et al. Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation study. J Intellect Disabil Res. 2019. PMID 30609152
67. 67 Deb S, Limbu B, et al. The UK psychiatrists' experience of rationalising antipsychotics in adults with intellectual disabilities. J Appl Res Intellect Disabil. 2023. PMID 36808782
68. 68 de Kuijper G, de Haan J, Deb S, Shankar R. Withdrawing antipsychotics for challenging behaviours in adults with intellectual disabilities: experiences and views of prescribers. Int J Environ Res Public Health. 2022. PMID 36554973
69. 69 Hassiotis A, Poppe M, et al. Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster randomised controlled trial. Health Technol Assess. 2018. PMID 29596045
70. 70 Balakrishnan A, Kulkarni K, Moirangthem S, et al. The Rights of Persons with Disabilities Act 2016: mental health implications. Indian J Psychol Med. 2019. PMID 30983658
71. 71 Girimaji SC, Srinath S. Perspectives of intellectual disability in India: epidemiology, policy, services for children and adults. Curr Opin Psychiatry. 2010. PMID 20489642
72. 72 Roy A, Sukumar GM, Madegowda RK, et al. Validity and reliability of the new NIMHANS intellectual disability screening instrument (NID-Screener) for children and adolescents in India. Asian J Psychiatr. 2024. PMID 39492081
73. 73 Gautham MS, Gururaj G, Varghese M, et al. The National Mental Health Survey of India (2016): prevalence, socio-demographic correlates and treatment gap of mental morbidity. Int J Soc Psychiatry. 2020. PMID 32126902
74. 74 Kishore MT, Nizamie A, Nizamie SH, Jahan M. Psychiatric diagnosis in persons with intellectual disability in India. J Intellect Disabil Res. 2004. PMID 14675227

The Rights of Persons with Disabilities Act 2016, the STOMP programme (NHS England, 2016) and the DSM-5 and ICD-11 severity frameworks are cited as primary documents and statute rather than indexed evidence. Indian service-availability detail reflects current practice and national survey data, not a single trial. Antipsychotic-induced movement disorders are covered in Aporia 09; treatment resistance and clozapine in Aporia 08.